Background
==========

Type 2 diabetes is a complex disease caused by both genetic and environmental factors. Although recent genome-wide association studies have identified several novel, possibly causative genes, the contribution of them to disease risk is still very limited \[[@B1]\]. Thus the genetic architecture of type 2 diabetes remained largely unknown. Previous genome-wide linkage studies in multiple ethnic populations, including Caucasians, Chinese and Pima Indian, showed that chromosome 1q21-q25 was the strongest and most replicable linkage signal in the human chromosome \[[@B2]-[@B9]\]. Although genome-wide association studies show no strong association signal in this region, whether variants harbored in this region conferred modest effect to the disease are worthy to be analyzed.

Dual specificity phosphatase 12 (*DUSP12*) and activating transcription factor 6 (*ATF6*) were two neighbored genes locating on the chromosome 1q21-q23. DUSP12 is a glucokinase - associated protein identified from rat hepatic cDNA library through yeast two-hybrid, using glucokinase as bait. It may participate in glycolysis in the liver and pancreatic beta-cell through dephosphorylation of glucokinase in the cytoplasm \[[@B10]\]. *ATF6*is a key sensor of endoplasmic reticulum stress. It activates unfolded protein response through regulating a group of genes encoding molecular chaperones and folding enzymes \[[@B11]\]. Previous studies identified several single nucleotide polymorphisms (SNPs) in this region associated with type 2 diabetes in different populations. Among them, rs2070150 (P145A) was firstly identified to be associated with type 2 diabetes in Pima Indian, while rs4579731, rs3820449 and rs10918215 were reported later in studies focusing on Caucasians and African Americans \[[@B12]-[@B15]\]. However, International Type 2 Diabetes 1q Consortium failed to detect any association signal on *DUSP12*and *ATF6*in a fine mapping study in multiethnic samples \[[@B16]\]. Even though, only 285 East Asian origin samples were included in the previous studies and no one analyzed the association between SNPs from this region and type 2 diabetes in large Asian samples. Therefore, we performed the present study, aiming to test if variants from *DUSP12*and *ATF6*played a role in the genetic susceptibility of type 2 diabetes in the Chinese.

Methods
=======

Participants
------------

In this case-control study, we recruited 3,700 unrelated Chinese Han subjects, including 1,892 case and 1,808 controls. All the subjects were eastern Chinese Han ancestry, residing in Shanghai and nearby region. In the present study, all case subjects were type 2 diabetes patients selected from Shanghai Diabetes Institute inpatient database. Control subjects were community-based populations enrolled from the Shanghai Diabetes Studies \[[@B17]\]. The inclusion and exclusion criteria for the cases and controls were described previously \[[@B17]\]. Briefly, all cases were type 2 diabetes patients defined according to 1999 WHO criteria (fasting plasma glucose ≥7.0 mmol/l and/or 2-h plasma glucose ≥11.1 mmol/l) and were treated with oral hypoglycemic agents and/or insulin. The control subjects were normal glucose tolerance defined based on fasting plasma glucose \<6.1 mmol/l and 2-h plasma glucose \<7.8 mmol/l. This study was approved by the institutional review board of Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital. Written informed consent was obtained from each participant.

Clinical measurement
--------------------

All subjects underwent detailed clinical investigations, as described previously \[[@B17]\]. Briefly, anthropometric parameters such as height, weight, waist and hip circumference (for the control subjects only) were measured. For the control subjects, blood samples were obtained at 0 and 120 min during the oral glucose tolerance tests (OGTTs) to measure plasma glucose and serum insulin levels. Lipid profiles such as total cholesterol and triglyceride were also obtained. Insulin resistance and pancreatic β-cell function were assessed by homeostasis model assessment (HOMA) \[[@B18]\]. HOMA-IR = fasting insulin × fasting plasma glucose ÷ 22.5, HOMA-B = 20 × fasting insulin ÷ (fasting plasma glucose ÷ 3.5).

SNPs selection, genotyping and quality control
----------------------------------------------

We selected 19 SNPs that spanning 197 kb of *DUPS12*and *ATF6*region, from 10 kb 5\' upstream the *DUSP12*to 2 kb 3\' downstream the *ATF6*. These SNPs could tag 98% of the SNPs with MAF over 0.1 derived from HapMap Phase III Chinese Han database under the threshold of r^2^≥0.7. Among them, 7 SNPs located in the coding region. The SNPs previously reported were either directly genotyped or in linkage disequilibrium (LD) with genotyped SNPs. All the SNPs were genotyped using Sequenom\'s MassARRAY iPLEX system (MassARRAY Compact Analyzer, Sequenom, San Diego, CA, USA). The key quality control requirements were: 1) sample call rates ≥75%; 2) SNP call rate ≥85%; 3) less than two discrepant genotypes of 100 duplicate samples; and 4) Hardy-Weinberg equilibrium test ≥0.05 in controls and cases respectively. After the quality control procedures of the genotypes, 71 individuals were excluded. And one SNP (rs3767635) failed Hardy-Weinberg equilibrium test. The average call rate for the remaining 18 SNPs was 97.5%, and the average concordance rate based on 100 duplicate comparisons for each SNP was 99.4%. Detailed information of the call rates and concordance rates for the SNPs was shown in the Additional file [1](#S1){ref-type="supplementary-material"} Table S1.

Statistical analyses
--------------------

Observed genotypes were tested for fit to the expectation of Hardy-Weinberg equilibrium using χ^2^test. Pairwise LD was estimated from the combined data of cases and controls calulating \|D\'\| and r^2^using Haploview (version 4.1) <http://www.broadinstitute.org/haploview/haploview>\[[@B19]\]. Haplotype block structure was determined using confidence interval algorithm \[[@B20]\] and haplotype frequencies were estimated by Expectation-Maximization algorithm \[[@B21]\] using Haploview (v 4.1). Allele, genotype and haplotype frequencies for cases and controls were compared using χ^2^test or Fisher\'s exact test. Odds ratios (ORs) with 95% confidence intervals (CIs) were presented. The genotype - disease association analyses were performed under the additive model adjusting age, gender and BMI as confounding factors by logistic regression. Quantitative traits with skewed distribution were natural logarithmically transformed to approximate univariate normality. Quantitative traits were analyzed under an additive genetic model by linear regression adjusted for age, sex, and BMI. All statistical analyses were performed by SAS (version 8.0; SAS Institute Inc., Cary, NC, USA) unless specified otherwise. A two-tailed *P*value \<0.05 was considered significant. The allele frequencies in HapMap populations and statistic power of the SNPs were shown in the Additional file [2](#S2){ref-type="supplementary-material"} Table S2.

Results
=======

A total of 18 SNPs were successfully genotyped in 3,629 individuals in the present study. The LD pattern of these SNPs was shown in Figure [1](#F1){ref-type="fig"}. Three haplotype blocks were constructed in this region.

![**Linkage disequilibrium plots for SNPs genotyped in *DUSP12 - ATF6*locus in the Chinese samples**. Shades of pink indicate the strength of pairwise LD based on \|D\'\|. Number shown are \|D\'\| of each SNP pair.](1471-2350-12-3-1){#F1}

The single SNP association analysis showed that no SNP was significantly associated with type 2 diabetes in our samples. The minimum *P*value was 0.0954 for rs10799941. Logistic regression analysis adjusting age, gender and BMI as confounding factors also suggested no association between SNPs and type 2 diabetes (Table [1](#T1){ref-type="table"}). For the haplotype analysis, we compared the haplotype distributions between cases and controls and observed that no haplotype was nominally associated with type 2 diabetes (Table [2](#T2){ref-type="table"}).

###### 

Allele frequencies and association to type 2 diabetes for SNPs in the DUSP12-ATF6 locus

  Gene       SNP          Chromosome position   Major/minor allele   Risk allele   Risk allele frequency   OR (95%CI)   *P*~allele~             *P*~genotype~   
  ---------- ------------ --------------------- -------------------- ------------- ----------------------- ------------ ----------------------- --------------- --------
  *DUSP12*   rs10799941   159974818             T,G                  T             0.540                   0.520        1.0821(0.9863-1.1873)   0.0954          0.1122
  *DUSP12*   rs1503814    159975743             C,T                  T             0.329                   0.316        1.0613(0.9616-1.1714)   0.2373          0.3788
  *DUSP12*   rs12021510   159975835             A,G                  A             0.930                   0.929        1.0141(0.8466-1.2147)   0.8794          0.9472
  *DUSP12*   rs12121310   159985839             A,C                  C             0.379                   0.367        1.0546(0.9572-1.1620)   0.2823          0.5793
  *DUSP12*   rs1063178    159988331             C,T                  T             0.460                   0.458        1.0074(0.9177-1.1060)   0.8766          0.7165
  *DUSP12*   rs1063179    159988828             C,T                  C             0.772                   0.762        1.0594(0.9498-1.1817)   0.3002          0.3300
  *DUSP12*   rs3820449    159993796             C,T                  C             0.694                   0.694        1.0002(0.9049-1.1056)   0.9964          0.6854
  *ATF6*     rs2070151    160014680             C,T                  T             0.311                   0.300        1.0512(0.9511-1.1619)   0.3282          0.2568
  *ATF6*     rs2271013    160020426             A,G                  G             0.310                   0.300        1.0506(0.9505-1.1612)   0.3338          0.2515
  *ATF6*     rs2271012    160020465             C,T                  T             0.317                   0.302        1.0706(0.9666-1.1858)   0.1908          0.1373
  *ATF6*     rs2070150    160027900             G,C                  C             0.312                   0.301        1.0568(0.9559-1.1685)   0.2805          0.2015
  *ATF6*     rs1135983    160027936             C,T                  T             0.309                   0.297        1.0563(0.9553-1.1680)   0.2856          0.2305
  *ATF6*     rs10918029   160062520             G,A                  G             0.780                   0.774        1.0360(0.9272-1.1575)   0.5326          0.6230
  *ATF6*     rs2340721    160116009             A,C                  C             0.349                   0.344        1.0197(0.9247-1.1244)   0.6959          0.9399
  *ATF6*     rs2341475    160145232             G,A                  G             0.658                   0.646        1.0531(0.9497-1.1677)   0.3268          0.4704
  *ATF6*     rs10918215   160166355             A,G                  G             0.432                   0.427        1.0223(0.9304-1.1234)   0.6460          0.4317
  *ATF6*     rs7522210    160193803             C,G                  G             0.433                   0.427        1.0258(0.9341-1.1264)   0.5940          0.3425
  *ATF6*     rs2499855    160196385             A,G                  A             0.897                   0.890        1.0753(0.9203-1.2563)   0.3606          0.5117

###### 

Association analyses of haplotypes in DUSP12-ATF6 locus with type 2 diabetes

  Haplotype                                                       Haplotype frequencies   *P*value   
  --------------------------------------------------------------- ----------------------- ---------- --------
  Block 1 (rs10799941-rs1503814)                                                                     
                                                                                                     
  GC                                                              0.449                   0.467      0.1199
  TT                                                              0.318                   0.304      0.1919
  TC                                                              0.222                   0.217      0.5799
  GT                                                              0.011                   0.013      0.5919
                                                                                                     
  Block 2 (rs12021510-rs12121310-rs1063178-rs1063179-rs3820449)                                      
                                                                                                     
  ACTCT                                                           0.307                   0.306      0.8928
  AACCC                                                           0.242                   0.236      0.5579
  AACTC                                                           0.228                   0.237      0.3592
  AATCC                                                           0.080                   0.089      0.1618
  GACCC                                                           0.070                   0.069      0.8911
  ACTCC                                                           0.074                   0.064      0.0897
                                                                                                     
  Block 3 (rs2070151-rs10918029-rs7522210-rs2499855)                                                 
                                                                                                     
  CGCA                                                            0.342                   0.341      0.9407
  TGGA                                                            0.304                   0.296      0.4348
  CACA                                                            0.218                   0.226      0.3917
  CGGG                                                            0.100                   0.107      0.3166
  CGGA                                                            0.021                   0.017      0.3030

We then analyzed the association between SNPs and quantitative traits related to glucose metabolism in the individuals with normal glucose regulation. No SNP was associated with plasma glucose and serum insulin levels at fasting status as well as 2-h after glucose stimulation. No significant association was detected between insulin sensitivity and beta cell function either (Table [3](#T3){ref-type="table"}).

###### 

Association between SNPs from DUSP12-ATF6 and clinical features related to glucose metabolism in the normal glucose regulation subjects

  SNP          Fasting glucose   2 h glucose   Fasting insulin   HOMA-IR   HOMA-B                                                                                       
  ------------ ----------------- ------------- ----------------- --------- -------- -------- --------- -------- -------- --------- -------- -------- --------- -------- --------
  rs10799941   0.0065            0.0164        0.6933            0.0325    0.0387   0.4024   -0.0087   0.0226   0.7019   -0.0076   0.0237   0.7492   -0.0164   0.0249   0.5116
  rs1503814    0.0098            0.0179        0.5833            0.0247    0.0425   0.5613   0.0023    0.0251   0.9273   0.0065    0.0262   0.8036   -0.0135   0.0277   0.6264
  rs12021510   0.0073            0.0322        0.8203            -0.0795   0.0760   0.2953   0.0039    0.0452   0.9319   0.0054    0.0473   0.9086   -0.0021   0.0499   0.9670
  rs12121310   0.0288            0.0173        0.0963            0.0740    0.0411   0.0719   -0.0066   0.0241   0.7858   0.0010    0.0253   0.9678   -0.0400   0.0267   0.1346
  rs1063178    0.0298            0.0165        0.0722            0.0356    0.0392   0.3639   0.0083    0.0230   0.7192   0.0162    0.0240   0.5008   -0.0259   0.0254   0.3068
  rs1063179    -0.0178           0.0192        0.3541            0.0082    0.0454   0.8561   -0.0241   0.0262   0.3590   -0.0258   0.0274   0.3483   -0.0090   0.0288   0.7552
  rs3820449    0.0216            0.0178        0.2256            0.0739    0.0421   0.0791   -0.0179   0.0247   0.4687   -0.0113   0.0259   0.6627   -0.0489   0.0273   0.0737
  rs2070151    -0.0187           0.0184        0.3094            -0.0112   0.0435   0.7970   0.0023    0.0254   0.9295   -0.0061   0.0266   0.8182   0.0328    0.0280   0.2426
  rs2271013    -0.0203           0.0184        0.2704            -0.0126   0.0435   0.7728   0.0014    0.0252   0.9559   -0.0073   0.0264   0.7822   0.0330    0.0278   0.2367
  rs2271012    -0.0196           0.0186        0.2934            -0.0193   0.0440   0.6615   0.0086    0.0257   0.7376   0.0004    0.0269   0.9883   0.0376    0.0285   0.1866
  rs2070150    -0.0177           0.0185        0.3397            -0.0154   0.0438   0.7249   0.0062    0.0257   0.8106   -0.0020   0.0269   0.9405   0.0349    0.0283   0.2178
  rs1135983    -0.0168           0.0185        0.3633            -0.0192   0.0438   0.6609   0.0128    0.0256   0.6180   0.0046    0.0268   0.8642   0.0427    0.0283   0.1314
  rs10918029   0.0075            0.0197        0.7027            0.0282    0.0467   0.5451   -0.0102   0.0271   0.7066   -0.0071   0.0284   0.8029   -0.0177   0.0300   0.5561
  rs2340721    -0.0023           0.0174        0.8958            0.0488    0.0410   0.2342   -0.0074   0.0239   0.7581   -0.0064   0.0250   0.7988   -0.0125   0.0264   0.6346
  rs2341475    0.0202            0.0187        0.2810            -0.0207   0.0445   0.6419   0.0021    0.0257   0.9350   0.0093    0.0269   0.7299   -0.0226   0.0289   0.4332
  rs10918215   0.0022            0.0167        0.8941            -0.0441   0.0396   0.2647   0.0120    0.0232   0.6054   0.0093    0.0243   0.7006   0.0193    0.0256   0.4501
  rs7522210    0.0001            0.0166        0.9945            -0.0425   0.0394   0.2809   0.0095    0.0230   0.6810   0.0061    0.0241   0.8001   0.0213    0.0253   0.3991
  rs2499855    0.0153            0.0266        0.5654            -0.0842   0.0630   0.1814   0.0172    0.0367   0.6391   0.0199    0.0384   0.6045   0.0023    0.0407   0.9546

Discussion
==========

Genome-wide linkage studies in various populations suggested the existence of multiple susceptibility gene(s) for type 2 diabetes at chromosome 1q21-q24 \[[@B2]-[@B9]\]. Several specific genes in this region, such as *LMNA*, *NOS1AP*and *ATF6*, were identified that they might confer risk for diabetes in some populations \[[@B12]-[@B16],[@B22]-[@B24]\]. Among these genes, *ATF6*is a strong candidate by its biological function in endoplasmic reticulum stress and unfolded protein response, which linked insulin demand with beta cell failure and diabetes. ATF6 is also the binding target of WFS1, a known type 2 diabetes susceptible gene, and mediates its effect on endoplasmic reticulum stress \[[@B25]\]. However, although we performed the association study by analyzing 18 SNPs in 3700 Chinese Han, we failed to find any evidence of association between SNPs from this locus and traits related to glucose metabolism in our samples. One possible explanation might be that the statistical power of our samples was not enough to detect the effects of this locus in the Chinese population. Although we had over 80% power to detect the association at the 0.05 level based on the previously reported ORs in non-Asian populations (1.2 \~ 1.3) and allele frequencies of reported SNPs in our Chinese samples, we could not exclude the possibility the reported effect size was overestimated due to the \"winner\'s curse\" effect or novel associated SNPs with lower minor allele frequencies in the Chinese existed, in this case our samples may not have sufficient power. Secondly, the relatively loose criteria for tagging SNP selection, which is the limitation of the current study, missed information for a group of SNPs in this region. As we used r^2^over 0.7 and minor allele frequency over 0.1 as SNPs selection criterion, we failed to capture 15(6.8%) SNPs if the stringent criterion r^2^over 0.8 and minor allele frequency over 0.05 was adopted. Thirdly, the LD pattern and allele frequencies differed between Chinese Hans and previously studied populations, which suggested population differences in the genetic architecture between Chinese and other ethnic populations, may also partly explain the lack of association between this locus and previously reported phenotypes. Finally we cannot exclude the possibility that rare variants within this region participated in the pathogenesis of diabetes as we only focused on the common ones.

Conclusion
==========

Our data suggests common variants within *DUSP12*and *ATF6*genes may not play a major role in glucose metabolism in the Chinese. However, due to the limitation of the current study, the effects of SNPs from this locus on type 2 diabetes need to be tested in further studies with larger East Asian origin samples and higher marker density.
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